Solara Active Pharma Sciences has informed that a meeting of Board of Directors of the Company is scheduled to be held on Friday, January 24, 2025, to consider and approve, the un-audited financial results (standalone and consolidated) of the Company for the Quarter and Nine months ended December 31, 2024, amongst other matters. In accordance with the Company's Code of Conduct to regulate, monitor and report trading by insiders, adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company is closed for the designated persons from January 1, 2025, till 48 hours after the announcement of financial results, up to January 26, 2025.
The above information is a part of company’s filings submitted to BSE.
